T cell-directed lysis of tumor cells expressing P-cadherin by these novel anti-P-cadherin/anti-CD3 DART molecules showed moderate cell killing activity (EC50 ~0.3–3.6 nM) for some but not all DARTs tested. Here, CDH3 is linked to neoplasm.